Model
Edge
Bellicum Pharmaceuticals, Inc
BLCM
Filing Type
8-K
Filing Date
1/23/2024
Updated
1/24/24, 9:00 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws, Shareholder votes, Other Events
EX-3.1
CERTIFICATE OF DESIGNATION OF SENIOR A JUNIOR PREFERRED STOCK OF BELLICUM PHARMACEUTICALS, INC., DATED JANUARY 24, 2024
EX-3.2
AMENDMENT TO AMENDED AND RESTATED BYLAWS OF BELLICUM PHARMACEUTICALS, INC., EFFECTIVE JANUARY 24, 2024